InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Besthof Robert, Directeur de la communication et des patients. Director active across 1 company, notably NRX Pharmaceuticals, Inc.. Cumulatively, 1 filings have been logged. Activity tracked since 16 August 2021. The latest transaction was disclosed on 16 August 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Robert Besthof is the Chief Communication & Patient Officer at NRX Pharmaceuticals, Inc. In this role, he is responsible for the company's communication strategy and patient engagement. His expertise in communication enables him to play a key role in promoting the company's initiatives and enhancing the patient experience. Robert is committed to ensuring clear and effective communication between NRX Pharmaceuticals and its stakeholders.